From reading in the other thread it seems like she wants to do cd20 as well as cd19 and cd38 maybe? I mean at least we'll get some really concrete answers on that and put the rituximab debate to bed at last if they do that.
I'm not very optimistic for this trial in particular but this is very good news because the isatuximab trial was supposed to be a platform trial with a drug of this class so hopefully that will now go ahead as planned too!
It looks like uplinza it works on cd19 not cd20 like rituximab...
I don't know about this. Something like daratumumab working out could give a huge boost to the basic science. But that is already happening. I think there are a few things like T cell depletion that we are very close to being at the point where a therapeutic experiment is justified.
At the same...
@Jonathan Edwards are there any academic physicians you know in the UK or even elsewhere who might fit this bill?
I know you're already thinking about this. I assume from your posts in this thread you have had some difficult conversations with doctors already, but surely there must be one...
I think it is this aspect of what has been done to us that is most odious and damaging, and it is this aspect that the wider public needs to understand. I think if there is a breakthrough and a change in perspective because of that, many people will be absolutely horrified that this could have...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.